A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier surveyed hospitals, health systems and other providers to identify which waivers and flexibilities they are still leveraging and the readiness of providers to unwind...
Premier submitted comments to the Patent and Trade Office and FDA on ways to ensure the patent system does not lead to increased pharmaceutical costs.
This brief survey is intended to capture incidents of workforce violence that have occurred in healthcare settings across the nation.
Watch this on-demand webinar to hear from Premier staff as they discuss the various new requirements and policies for providers, as well as what trends...
To help separate fact from fiction, here are misconceptions about AP automation we regularly hear from healthcare providers — and the truths behind them.
Premier applauds FDA for addressing the inequities that exists for individuals who identify as LGBTQ+ and their eligibility to donate blood.
Premier provides input on the Administration's proposal to modernize the 40-year-old law governing providers' access to their patients' data on substance use.
As the 118th Congress commences, government leaders have an opportunity to coalesce around meaningful healthcare policy solutions.
Take Premier's brief survey on what waivers are still being leveraged and the readiness of providers to unwind from the COVID-19 public health emergency.
Watch this on-demand webinar to learn more about these proposed regulatory changes and how they could impact your organization.
Premier responds to healthcare provisions in the FY 2023 omnibus funding package released by Congress.
Premier urges FDA . Premier urges the FDA to address three critical areas to ensure success in reducing disparities for medical devices.